Browsing by Author Jackisch, Christian

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2014Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete responseBoyle, Frances; Barrios, Carlos; De Azambuja, Evandro; Di Cosimo, Serena; et al, Various; Holmes, Andrew P; Holmes, Eileen; Jackisch, Christian; Lang, Istvan; Perez, E. A.; Piccart-Gebhart, Martine; Smith, Ian (Prof); Swaby, Ramona F; Untch, Michael; Xu, Binghe; Northern Clinical School: MedicineLapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response, The Lancet Oncology, vol.15, 10, 2014,pp 1137-1146
2010Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late RelapseBrown, Christopher; Gebski, Val; Aavall-Lundqvist, Elisabeth; du Bois, Andreas; Ferrero, Annamaria; Heywood, Mark; Jackisch, Christian; Joly, Florence; Kristensen, Gunnar; Le Fur, Nathalie; Lortholary, Alain; Pignata, Sandro; Pujade-Lauraine, Eric; Sehouli, Jalid; Vasey, Paul A.; Vergote, Ignace; Volgger, Birgit; Wagner, Uwe; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse, Journal of Clinical Oncology, vol.28, 20,pp 3323-3329